Veves, Aristidis
Harvard Medical School,
United States
2025 Rank: 68111
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1449 out of 96207 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68111 | 69725 |
| Total Cites | 17613 | 19793 |
| H-index | 64 | 69 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2540 | 2861 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 10390 | 11350 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13963 | 15003 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
11.01%
|
|
Veves, Aristidis
Harvard Medical School,
United States
2024 Rank: 71424
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1529 out of 92197 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71424 | 74045 |
| Total Cites | 16172 | 18259 |
| H-index | 62 | 65 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 4 | 5 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2447 | 2761 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 9703 | 10634 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12755 | 13744 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
11.43%
|
|
Veves, Aristidis
Harvard Medical School,
United States
2023 Rank: 74822
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1635 out of 87976 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74822 | 80323 |
| Total Cites | 14857 | 16843 |
| H-index | 59 | 63 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2375 | 2685 |
| Number of Single+First+Last Authored Papers | 144 | 144 |
| Total Cites to Single+First+Last Authored Papers | 9008 | 9902 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11706 | 12642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
11.79%
|
|
Veves, Aristidis
Harvard Medical School,
United States
2022 Rank: 72568
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1602 out of 84176 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72568 | 78188 |
| Total Cites | 13563 | 15394 |
| H-index | 56 | 60 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2265 | 2560 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 8262 | 9104 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10656 | 11511 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.34 |
| Self-Citation Percentage |
11.89%
|
|
Veves, Aristidis
Harvard Medical School,
United States
2021 Rank: 70787
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1582 out of 81805 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70787 | 77389 |
| Total Cites | 12972 | 14757 |
| H-index | 55 | 59 |
| Hm-index | 21 | 21 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2176 | 2466 |
| Number of Single+First+Last Authored Papers | 140 | 140 |
| Total Cites to Single+First+Last Authored Papers | 7905 | 8735 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10194 | 11018 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.34 |
| Self-Citation Percentage |
12.10%
|
|
Veves, Aristidis
Harvard Medical School,
United States
2020 Rank: 82774
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Dermatology & Venereal Diseases
Rank in SubField 1: 1882 out of 69094 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82774 | 87334 |
| Total Cites | 11650 | 13285 |
| H-index | 52 | 56 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 2058 | 2343 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 7132 | 7906 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9103 | 9857 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.35 |
| Self-Citation Percentage |
12.31%
|
|